JYONG BIOTECH LTD.
MENSLoading price...
Overview
Previous Close51.82
Open54.00
Ask59.99
Bid59.50
Day's Range52.20 - 58.82
52 Week Range6.01 - 67.00
PE Ratio(TTM)--
Market Cap4.37B
Volume131.48k
Avg. Volume218.76k
Profit/Loss
| PARTICULARS | ||||||
|---|---|---|---|---|---|---|
| No results to display | ||||||
Company Profile
Sector: Healthcare
Industry: Biotechnology
HQ Location: New Taipei City, Taiwan
Website: https://jyongbio.com
CEO & Chairwoman of the Board: Ms. Fu-Feng Kuo
About Company:
Jyong Biotech Ltd., a science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops MCS-2 for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.